Financials
- Market Capitalization 264.83 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.7
Fiyat/satışlar oranı
0.05
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3413 | GLSI Greenwich LifeSciences, Inc. - Common stock | 18.57 USD | -6.21% | -9.59% | -23.96% | +73.71% | 272.57 M USD | ||
| 3429 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.97 USD | -7.51% | -10.45% | +23.90% | +328.26% | 265.09 M USD | ||
| 3455 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.96 USD | -3.92% | -1.01% | +15.29% | +1.03% | 258.78 M USD | ||
| 3462 | TRDA Entrada Therapeutics, Inc. - Common Stock | 6.60 USD | -4.62% | -13.84% | +0.15% | -5.31% | 256.22 M USD |